细胞癌-话题@MedSci

#细胞癌#

1086篇内容 | 2810人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1979171, encodeId=fbdc19e9171c7, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=J Gastroenterology H：肌肉体积在乐伐替尼治疗肝细胞癌中的临床重要性, objectType=article, longId=214380, objectId=623c21438048, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=623c21438048, replyNumber=0, likeNumber=97, createdTime=2022-03-14, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=623c21438048, moduleTitle=J Gastroenterology H：肌肉体积在乐伐替尼治疗肝细胞癌中的临床重要性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=623c21438048)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979243, encodeId=25d619e9243f3, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Front Oncol：甲状腺激素比值对晚期转移性肾细胞癌患者的预后价值:来自Meet-URO 14研究, objectType=article, longId=221109, objectId=e61322110956, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e61322110956, replyNumber=0, likeNumber=75, createdTime=2022-08-03, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e61322110956, moduleTitle=Front Oncol：甲状腺激素比值对晚期转移性肾细胞癌患者的预后价值:来自Meet-URO 14研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e61322110956)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979162, encodeId=980319e916279, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Br J Cancer：肿瘤邻近组织、血浆和唾液中相关基因突变研究揭示头颈部鳞状细胞癌复发的进化过程, objectType=article, longId=213954, objectId=133d21395428, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=133d21395428, replyNumber=0, likeNumber=62, createdTime=2021-11-26, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=133d21395428, moduleTitle=Br J Cancer：肿瘤邻近组织、血浆和唾液中相关基因突变研究揭示头颈部鳞状细胞癌复发的进化过程, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=133d21395428)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979304, encodeId=983019e930446, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Liver Cancer：仑伐替尼联合或不联合药物洗脱微球经动脉化疗栓塞治疗不可切除晚期肝细胞癌的疗效, objectType=article, longId=300542, objectId=048f300542db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=048f300542db, replyNumber=0, likeNumber=55, createdTime=2022-11-26, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=048f300542db, moduleTitle=Liver Cancer：仑伐替尼联合或不联合药物洗脱微球经动脉化疗栓塞治疗不可切除晚期肝细胞癌的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=048f300542db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979308, encodeId=859a19e9308a6, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=BMC Cancer：仑伐替尼联合PD-1抑制剂治疗晚期肝细胞癌的真实世界疗效, objectType=article, longId=301506, objectId=0b2e301506ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b2e301506ca, replyNumber=0, likeNumber=103, createdTime=2022-05-06, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b2e301506ca, moduleTitle=BMC Cancer：仑伐替尼联合PD-1抑制剂治疗晚期肝细胞癌的真实世界疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b2e301506ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979247, encodeId=968919e9247c6, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Clinical Nutrition: 骨骼肌密度和内脏脂肪组织指数与肾细胞癌的存活率相关, objectType=article, longId=221169, objectId=03c1221169ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=03c1221169ae, replyNumber=0, likeNumber=99, createdTime=2021-12-03, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=03c1221169ae, moduleTitle=Clinical Nutrition: 骨骼肌密度和内脏脂肪组织指数与肾细胞癌的存活率相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=03c1221169ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979192, encodeId=c17619e9192d3, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=J Immunother Cancer：Ipilimumab+Nivolumab治疗转移性肾细胞癌伴有脑转移患者的疗效, objectType=article, longId=217179, objectId=edee21e17926, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=edee21e17926, replyNumber=0, likeNumber=69, createdTime=2021-09-29, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=edee21e17926, moduleTitle=J Immunother Cancer：Ipilimumab+Nivolumab治疗转移性肾细胞癌伴有脑转移患者的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=edee21e17926)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979177, encodeId=225119e917768, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=阿替利珠单抗对于非小细胞癌的治疗效果如何？, objectType=article, longId=214866, objectId=11fe2148660c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=11fe2148660c, replyNumber=0, likeNumber=68, createdTime=2022-04-10, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=11fe2148660c, moduleTitle=阿替利珠单抗对于非小细胞癌的治疗效果如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=11fe2148660c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979178, encodeId=fe2919e9178cf, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Eur Urol Oncol：晚期肾细胞癌患者接受一线Pembrolizumab加Axitinib治疗时出现的肝脏毒性的特征和管理, objectType=article, longId=214935, objectId=823a21493535, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=823a21493535, replyNumber=0, likeNumber=107, createdTime=2021-12-05, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=823a21493535, moduleTitle=Eur Urol Oncol：晚期肾细胞癌患者接受一线Pembrolizumab加Axitinib治疗时出现的肝脏毒性的特征和管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=823a21493535)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979225, encodeId=1a8c19e9225ba, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Cancer Commun：紫杉醇脂质体+顺铂vs 吉西他滨+顺铂一线治疗局部晚期或转移性肺鳞状细胞癌的疗效：多中心随机对照研究, objectType=article, longId=219626, objectId=89d3219626c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=89d3219626c9, replyNumber=0, likeNumber=76, createdTime=2022-09-15, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89d3219626c9, moduleTitle=Cancer Commun：紫杉醇脂质体+顺铂vs 吉西他滨+顺铂一线治疗局部晚期或转移性肺鳞状细胞癌的疗效：多中心随机对照研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=89d3219626c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979190, encodeId=846d19e91900c, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Clin Gastroenterology H: HBeAg 对慢性乙型肝炎患者口服抗病毒药物治疗期间肝细胞癌风险的影响, objectType=article, longId=217119, objectId=e86e21e119cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e86e21e119cf, replyNumber=0, likeNumber=88, createdTime=2022-07-26, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e86e21e119cf, moduleTitle=Clin Gastroenterology H: HBeAg 对慢性乙型肝炎患者口服抗病毒药物治疗期间肝细胞癌风险的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e86e21e119cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979198, encodeId=c0d619e9198fe, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Front Oncol：索拉非尼辅助治疗可改善高复发风险的肝细胞癌（HCC）患者切除术后的总生存期, objectType=article, longId=217593, objectId=2b2621e5937a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b2621e5937a, replyNumber=0, likeNumber=75, createdTime=2022-03-08, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b2621e5937a, moduleTitle=Front Oncol：索拉非尼辅助治疗可改善高复发风险的肝细胞癌（HCC）患者切除术后的总生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b2621e5937a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979227, encodeId=f9f719e92270a, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=European Radiology：CT放射组学列线图对腭扁桃体鳞状细胞癌和非霍奇金淋巴瘤的鉴别诊断, objectType=article, longId=219719, objectId=5cae219e19b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5cae219e19b0, replyNumber=0, likeNumber=80, createdTime=2022-10-18, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5cae219e19b0, moduleTitle=European Radiology：CT放射组学列线图对腭扁桃体鳞状细胞癌和非霍奇金淋巴瘤的鉴别诊断, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5cae219e19b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979254, encodeId=4d3619e9254d0, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Liver Cancer：卡博替尼（Cabozantinib）对比安慰剂治疗晚期肝细胞癌患者的基于血清标志物的预后分析：3期临床研究CELESTIAL, objectType=article, longId=221546, objectId=86b522154637, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=86b522154637, replyNumber=0, likeNumber=79, createdTime=2022-06-16, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=86b522154637, moduleTitle=Liver Cancer：卡博替尼（Cabozantinib）对比安慰剂治疗晚期肝细胞癌患者的基于血清标志物的预后分析：3期临床研究CELESTIAL, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=86b522154637)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979161, encodeId=13d419e916168, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=罗氏PD-1/LAG-3双特异性抗体在中国申报临床，有望用于转移性黑色素瘤、非小细胞肺癌、食管鳞状细胞癌、晚期肝癌多种适应症治疗, objectType=article, longId=213744, objectId=3257213e448e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3257213e448e, replyNumber=0, likeNumber=66, createdTime=2021-08-06, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3257213e448e, moduleTitle=罗氏PD-1/LAG-3双特异性抗体在中国申报临床，有望用于转移性黑色素瘤、非小细胞肺癌、食管鳞状细胞癌、晚期肝癌多种适应症治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3257213e448e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979124, encodeId=059a19e912435, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Eur Urol：Lenvatinib+Everolimus治疗晚期非透明细胞肾细胞癌患者的单臂、多中心和2期研究, objectType=article, longId=211527, objectId=c72c21152e19, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c72c21152e19, replyNumber=0, likeNumber=77, createdTime=2021-10-13, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c72c21152e19, moduleTitle=Eur Urol：Lenvatinib+Everolimus治疗晚期非透明细胞肾细胞癌患者的单臂、多中心和2期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c72c21152e19)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979121, encodeId=9ea019e912195, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Lancet oncol：Cemiplimab在局部晚期基底细胞癌中的抗肿瘤活性令人可期, objectType=article, longId=211377, objectId=f1712113e75f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f1712113e75f, replyNumber=0, likeNumber=47, createdTime=2022-03-27, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f1712113e75f, moduleTitle=Lancet oncol：Cemiplimab在局部晚期基底细胞癌中的抗肿瘤活性令人可期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f1712113e75f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979251, encodeId=cccf19e9251e2, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Hepatology：糖尿病药物和血糖控制可以降低非酒精性脂肪肝患者肝细胞癌的风险, objectType=article, longId=221272, objectId=c58b2212e2e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c58b2212e2e9, replyNumber=0, likeNumber=100, createdTime=2022-06-23, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c58b2212e2e9, moduleTitle=Hepatology：糖尿病药物和血糖控制可以降低非酒精性脂肪肝患者肝细胞癌的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c58b2212e2e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979120, encodeId=590619e9120ed, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=肝细胞癌的分子靶向药物与免疫抑制剂联合治疗及其他联合治疗, objectType=article, longId=211270, objectId=a5bb2112e0e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a5bb2112e0e5, replyNumber=0, likeNumber=85, createdTime=2021-07-08, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a5bb2112e0e5, moduleTitle=肝细胞癌的分子靶向药物与免疫抑制剂联合治疗及其他联合治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a5bb2112e0e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979133, encodeId=7cc219e9133fb, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=JAMA子刊：延迟手术会明显增加非小细胞癌患者复发风险！, objectType=article, longId=212013, objectId=571f212013b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=571f212013b7, replyNumber=0, likeNumber=74, createdTime=2021-09-19, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=571f212013b7, moduleTitle=JAMA子刊：延迟手术会明显增加非小细胞癌患者复发风险！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=571f212013b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

细胞癌

2020-05-29

qingting (审核中...)

前往app查看评论内容

#细胞癌#

J Gastroenterology H：肌肉体积在乐伐替尼治疗肝细胞癌中的临床重要性

2022-03-14

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Front Oncol：甲状腺激素比值对晚期转移性肾细胞癌患者的预后价值:来自Meet-URO 14研究

2022-08-03

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Br J Cancer：肿瘤邻近组织、血浆和唾液中相关基因突变研究揭示头颈部鳞状细胞癌复发的进化过程

2021-11-26

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Liver Cancer：仑伐替尼联合或不联合药物洗脱微球经动脉化疗栓塞治疗不可切除晚期肝细胞癌的疗效

2022-11-26

qingting (审核中...)

前往app查看评论内容

#细胞癌#

BMC Cancer：仑伐替尼联合PD-1抑制剂治疗晚期肝细胞癌的真实世界疗效

2022-05-06

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Clinical Nutrition: 骨骼肌密度和内脏脂肪组织指数与肾细胞癌的存活率相关

2021-12-03

qingting (审核中...)

前往app查看评论内容

#细胞癌#

J Immunother Cancer：Ipilimumab+Nivolumab治疗转移性肾细胞癌伴有脑转移患者的疗效

2021-09-29

qingting (审核中...)

前往app查看评论内容

#细胞癌#

阿替利珠单抗对于非小细胞癌的治疗效果如何？

2022-04-10

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Eur Urol Oncol：晚期肾细胞癌患者接受一线Pembrolizumab加Axitinib治疗时出现的肝脏毒性的特征和管理

2021-12-05

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Cancer Commun：紫杉醇脂质体+顺铂vs 吉西他滨+顺铂一线治疗局部晚期或转移性肺鳞状细胞癌的疗效：多中心随机对照研究

2022-09-15

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Clin Gastroenterology H: HBeAg 对慢性乙型肝炎患者口服抗病毒药物治疗期间肝细胞癌风险的影响

2022-07-26

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Front Oncol：索拉非尼辅助治疗可改善高复发风险的肝细胞癌（HCC）患者切除术后的总生存期

2022-03-08

qingting (审核中...)

前往app查看评论内容

#细胞癌#

European Radiology：CT放射组学列线图对腭扁桃体鳞状细胞癌和非霍奇金淋巴瘤的鉴别诊断

2022-10-18

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Liver Cancer：卡博替尼（Cabozantinib）对比安慰剂治疗晚期肝细胞癌患者的基于血清标志物的预后分析：3期临床研究CELESTIAL

2022-06-16

qingting (审核中...)

前往app查看评论内容

#细胞癌#

罗氏PD-1/LAG-3双特异性抗体在中国申报临床，有望用于转移性黑色素瘤、非小细胞肺癌、食管鳞状细胞癌、晚期肝癌多种适应症治疗

2021-08-06

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Eur Urol：Lenvatinib+Everolimus治疗晚期非透明细胞肾细胞癌患者的单臂、多中心和2期研究

2021-10-13

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Lancet oncol：Cemiplimab在局部晚期基底细胞癌中的抗肿瘤活性令人可期

2022-03-27

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Hepatology：糖尿病药物和血糖控制可以降低非酒精性脂肪肝患者肝细胞癌的风险

2022-06-23

qingting (审核中...)

前往app查看评论内容

#细胞癌#

肝细胞癌的分子靶向药物与免疫抑制剂联合治疗及其他联合治疗

2021-07-08

qingting (审核中...)

前往app查看评论内容

#细胞癌#

JAMA子刊：延迟手术会明显增加非小细胞癌患者复发风险！

2021-09-19

科室
- - 订阅+
  - 更多科室
工具
服务